Semaglutide Frequency: How Often You Take Wegovy and Why It Works That Way

Step 1, understanding why weekly works (and where the misconception starts)

Most medicines patients are familiar with need to be taken daily or even several times a day, so a once-weekly injection can feel strange at first. A common reaction is to wonder whether one dose per week can really be enough. It can, and the biology explains why. Semaglutide is a GLP-1 receptor agonist with a plasma half-life of around seven days, achieved through a fatty-acid chain attached to the molecule that slows its breakdown and keeps it bound to albumin in the bloodstream. That means the medicine is still meaningfully active when you come back the following week, not wearing off halfway through. The NHS notes this pharmacological profile on its semaglutide medicines page, and it is the property that separates Wegovy from the shorter-acting GLP-1 medicines that did once require daily injection. If you want to understand more about what semaglutide is and how it works as a treatment, that page covers the medicine in full. You pick a day of the week that suits your routine, and you stay with it.

There is no clinical advantage to injecting more often. The receptors are already occupied; a second dose in the same week would not add benefit and would raise the risk of side effects, particularly gastrointestinal ones. Once weekly is both the minimum and the maximum the licence supports.

Step 2, moving through the titration steps at the right pace

The dose schedule for Wegovy is a staircase, not a ladder you sprint up. Starting at 0.25 mg for the first four weeks is a deliberate system-settling phase, the job of that pen is to let your body adjust to the GLP-1 signal before the dose climbs. Nausea, the most commonly reported side effect, is usually at its sharpest after a dose increase, so the four-week gaps give that to settle before the next step.

From 0.25 mg the sequence moves to 0.5 mg, then 1.0 mg, then 1.7 mg, and finally 2.4 mg. If you are considering how Wegovy's titration compares to the broader semaglutide dosing sequence, that page covers the schedule in more detail. The prescriber decides at each review whether you are ready to increase, so the four weeks is a minimum, not a guarantee of progression. NICE's appraisal of semaglutide for weight management, TA875, recommends considering stopping treatment if less than five per cent weight loss has occurred after six months on the maintenance dose, which makes clinical review at each stage genuinely important, not just paperwork.

Patients established on 2.4 mg who are moving to the newer 7.2 mg strength go through the same prescriber-led assessment first; availability of specific dose formats is confirmed at consultation.

Step 3, choosing and keeping your injection day

You can inject Wegovy on any day of the week, at any time of day, with or without food. The practical rule is consistency: choose a day you will remember and stick to it. Many people anchor it to something fixed, the same evening each week, a day they are reliably at home. If your schedule changes and you need to move your injection day, it is possible to shift it by a day or two as long as at least two days separate consecutive doses, though the specifics of how to do that safely belong in the Patient Information Leaflet and a conversation with your prescriber, not in general content.

If a dose is missed, the window matters. If fewer than five days have passed since the missed dose was due, take it as soon as you remember and then resume your usual day. If more than five days have passed, skip that dose and wait for your scheduled injection day. Never take two doses in the same week. This guidance comes directly from the prescribing information, and our FAQs touch on common timing questions our clinical team hears regularly.

Step 4, what the frequency means for eligibility and ongoing review

Wegovy is a prescription-only medicine licensed for adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition such as high blood pressure or type 2 diabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. The once-weekly frequency does not change based on eligibility, what changes is the dose level and whether the prescriber judges ongoing treatment appropriate.

Semaglutide's effectiveness is rooted in its molecular design, and readers who are curious about the peptide sequence that gives semaglutide its structure or who want to explore how the amino acid sequence of semaglutide differs from natural GLP-1 will find both of those covered in detail on their respective pages. For a broader view of what private treatment involves, our Wegovy treatment page covers the full picture, and if you want to see how the cost of semaglutide treatment breaks down in the UK private market, the Wegovy price comparison page sets out what different providers include in a quoted price. At nume, a named GPhC-registered Independent Prescriber reviews every consultation (not automated software) and that review happens on the same day you submit. If you are ready to check whether Wegovy is appropriate for you, check your eligibility with our free consultation.